In myopericarditis, which corticosteroid should be given and what is the appropriate dosing regimen?

Myopericarditis: Corticosteroid Selection and Dosing

Corticosteroids should be avoided as first-line therapy in myopericarditis; when they are required—after NSAIDs and colchicine have failed or are contraindicated and infection has been excluded—use prednisone 0.2–0.5 mg/kg/day (low-to-moderate dose), never high-dose prednisone (1 mg/kg/day), because high doses triple the risk of recurrence and promote chronic disease. 1, 2

When Corticosteroids Are Indicated

Corticosteroids should be reserved for specific scenarios only 1:

• NSAID contraindications: true allergy, recent peptic ulcer or gastrointestinal bleeding, oral anticoagulation with high bleeding risk 1
• NSAID/colchicine failure: incomplete response after an adequate trial of first-line therapy 1
• Specific indications: systemic inflammatory diseases, post-pericardiotomy syndrome, pregnancy 1
• Infection exclusion mandatory: bacterial and tuberculous causes must be ruled out before initiating steroids 1, 3

Prednisone Dosing Regimen

Starting Dose

• Prednisone 0.2–0.5 mg/kg/day (low-to-moderate dose range) 1, 3
• Avoid doses >50 mg/day except for special autoimmune cases, and only for a few days with rapid taper to 25 mg/day 1
• Never use prednisone 1 mg/kg/day (high-dose)—this triples recurrence risk (hazard ratio 3.61) and increases side effects 2

Tapering Protocol (Critical for Success)

The taper must be extremely slow, particularly below 25 mg/day 1:

Current Daily Dose	Reduction Amount	Interval
>50 mg	10 mg	Every 1–2 weeks
50–25 mg	5–10 mg	Every 1–2 weeks
25–15 mg	2.5 mg	Every 2–4 weeks
<15 mg	1.25–2.5 mg	Every 2–6 weeks

1

Mandatory Co-Therapy

• Colchicine must be continued throughout steroid therapy (0.5 mg twice daily if ≥70 kg; 0.5 mg once daily if <70 kg) for at least 6 months 1, 3
• Corticosteroids should be added to NSAIDs and colchicine as triple therapy, not replace them 1
• Each dose reduction requires both symptom resolution and normalized C-reactive protein (CRP) 1, 4

Monitoring Requirements

• CRP before every dose reduction: tapering is permitted only when CRP is normal and symptoms absent 1, 4
• Critical threshold: the 10–15 mg/day prednisone range is where recurrences most commonly occur; use 1.0–2.5 mg decrements at 2–6 week intervals in this zone 1
• Serial CRP measurements guide the entire taper duration 4

Why High-Dose Steroids Fail

• High-dose prednisone (1 mg/kg/day) is associated with 3.6-fold higher risk of recurrence, more side effects, and more hospitalizations compared to low-dose (0.2–0.5 mg/kg/day) 2
• Corticosteroids favor chronicity and drug dependence when used as first-line therapy 1
• Recurrence rates increase from 15–30% to approximately 50% when steroids are used inappropriately 1, 5

First-Line Therapy (What Should Be Used Instead)

Before considering steroids, the standard regimen is 3, 6, 5:

• Ibuprofen 600 mg every 8 hours or aspirin 750–1000 mg every 8 hours 3
• Colchicine 0.5 mg twice daily (≥70 kg) or 0.5 mg once daily (<70 kg) for 3 months 3, 6
• Proton-pump inhibitor for gastroprotection 3
• Continue full-dose NSAID for 1–2 weeks until chest pain resolves and CRP normalizes 3
• Taper NSAIDs gradually: reduce ibuprofen by 200–400 mg or aspirin by 250–500 mg every 1–2 weeks 3

This regimen reduces recurrence from 37.5% to 16.7% (absolute risk reduction 20.8%) 5

Special Considerations in Myopericarditis

• Colchicine is safe and effective specifically in myopericarditis (pericarditis with myocardial involvement), reducing recurrence from 43.8% to 19.2% 6
• Corticosteroid use is an independent risk factor for recurrence in myopericarditis (HR 2.27) 6
• The 2025 ESC guidelines introduce the term "inflammatory myopericardial syndrome" (IMPS) to unify management of myocarditis, pericarditis, and overlap syndromes 7, 8

Common Pitfalls to Avoid

• Do not use steroids first-line—they worsen long-term outcomes 1, 3, 5
• Do not taper faster than the protocol above—rapid tapering causes recurrence 1
• Do not reduce steroid dose without confirming normal CRP—symptom resolution alone is insufficient 1, 4
• Do not omit colchicine when using steroids—colchicine is mandatory throughout steroid therapy 1, 3
• Do not start steroids before excluding infection—particularly tuberculosis and bacterial causes 1, 3